Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gsk2141795
1. 1047634-65-0
2. Gsk2141795
3. Gsk2141795c
4. Gsk795
5. Gsk-2141795
6. Zxm835lq5e
7. Akt Inhibitor Gsk2141795
8. Akt Inhibitor Gsk-2141795
9. Uprosertib (gsk2141795)
10. Gsk-2141795c
11. N-((s)-1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)furan-2-carboxamide
12. 2-furancarboxamide, N-((1s)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-
13. N-((1s)-1-(aminomethyl)-2-(3,4-difluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)furan-2-carboxamide
14. N-[(2s)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide
15. Uprosertib [usan:inn]
16. Unii-zxm835lq5e
17. Uprosertib [usan]
18. Uprosertib [inn]
19. Uprosertib (usan/inn)
20. Uprosertib [who-dd]
21. Schembl168584
22. Uprosertib, Gsk2141795
23. Gtpl7902
24. Chembl3137336
25. Bcp28204
26. Ex-a1593
27. Bdbm50170284
28. Mfcd28144686
29. Nsc778368
30. Nsc800960
31. S7492
32. Zinc43197676
33. Akos027323909
34. Ccg-268992
35. Db11969
36. Nsc-778368
37. Nsc-800960
38. Ncgc00390653-01
39. Ac-30940
40. Hy-15965
41. D10674
42. F20800
43. Q27089099
44. Gsk-2141795; Gsk2141795; Gsk 2141795; Gsk795; Gsk-795; Gsk 795.
45. (s)-n-(1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)furan-2-carboxamide
46. N-{(1s)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-furancarboxamide
| Molecular Weight | 429.2 g/mol |
|---|---|
| Molecular Formula | C18H16Cl2F2N4O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 428.0618375 g/mol |
| Monoisotopic Mass | 428.0618375 g/mol |
| Topological Polar Surface Area | 86.1 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 550 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
18
PharmaCompass offers a list of Uprosertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Uprosertib manufacturer or Uprosertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Uprosertib manufacturer or Uprosertib supplier.
PharmaCompass also assists you with knowing the Uprosertib API Price utilized in the formulation of products. Uprosertib API Price is not always fixed or binding as the Uprosertib Price is obtained through a variety of data sources. The Uprosertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Uprosertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Uprosertib, including repackagers and relabelers. The FDA regulates Uprosertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Uprosertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Uprosertib supplier is an individual or a company that provides Uprosertib active pharmaceutical ingredient (API) or Uprosertib finished formulations upon request. The Uprosertib suppliers may include Uprosertib API manufacturers, exporters, distributors and traders.
Uprosertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Uprosertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Uprosertib GMP manufacturer or Uprosertib GMP API supplier for your needs.
A Uprosertib CoA (Certificate of Analysis) is a formal document that attests to Uprosertib's compliance with Uprosertib specifications and serves as a tool for batch-level quality control.
Uprosertib CoA mostly includes findings from lab analyses of a specific batch. For each Uprosertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Uprosertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Uprosertib EP), Uprosertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Uprosertib USP).
